Advertisement

Effects of Mycoplasmas on Lymphocyte Cell Cultures

  • Gerard J. McGarrity
Part of the Cellular Senescence and Somatic Cell Genetics book series (CSSCG, volume 3)

Abstract

The use of human lymphocyte cultures for cytogenetic studies was reported by Chrustschoff and Berlin in 1935 (1). Because of difficulties in propagation and maintenance of lymphocyte cell cultures, work was limited. Normal leukocytes do not ordinarily divide in peripheral blood although some do have mitotic potential. Early studies were designed to determine what factors could activate this latent potential. Plasma concentration, oxygen tension and carbon dioxide had only minor effects. In 1955, Rigas and Osgood reported the characteristics of phytohemagglutinin (PHA), a mitogen present in the red kidney bean, Phaseolus vulgaris (2). This plant extract was originally used to agglutinate erythrocytes in obtaining leukocytes from whole blood, and was shown to induce mitosis in leukocytes.

Keywords

Lymphocyte Culture Lymphocyte Transformation Maple Syrup Urine Disease Interferon Production Leukemoid Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Crustschoff, G.K. and E.A. Berlin. 1935. Cytological investigations on cultures of normal human blood. J. Genet. 31: 243–251.CrossRefGoogle Scholar
  2. 2.
    Rigas, D.A. and E.E. Osgood. 1955. Purification and properties of the phytohemagglutinin of Phaseolus vulgaris. J. Biol. Chem. 212: 607–609.PubMedGoogle Scholar
  3. 3.
    Nowell, P.C. 1960. Differentiation of human leukemic leukocytes in tissue culture. Exp. Cell Res. 19: 267–277PubMedCrossRefGoogle Scholar
  4. 4.
    Nowell, P.C. 1960. Phytohemagglutinin: an initiator of mitosis in cultures of normal human leukocytes. Cancer Res. 20: 462–466.PubMedGoogle Scholar
  5. 5.
    Smith, G.F. 1973. The lymphocyte in culture: historic perspective. In: Birth Defects, Original Article Series, Long-term Lymphocyte Cultures in Human Genetics. The National Foundation -March of Dimes. Vol. IX (No. 1): 5–8.Google Scholar
  6. 6.
    Moorhead, P.S., P.C. Nowell, W.J. Mellman, D.M. Battigs and D.A. Hungerford. 1960. Chromosome preparations of leukocytes cultured from human peripheral blood. Exp. Cell Res. 20: 613–616.PubMedCrossRefGoogle Scholar
  7. 7.
    Henle, W., V. Diehl, G. Kohn, H. zur Hausen, and G. Henle. 1967. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157: 1064–1065.PubMedCrossRefGoogle Scholar
  8. 8.
    Gerber, P. 1973. The role of Epstein-Barr virus in establishing long term human lymphocyte cultures. In: Birth Defects Original Article Series. “Long-Term Lymphocyte Cultures in Human Genetics. Vol. IX (No. 1) The National Foundation-March of Dimes:20–30.Google Scholar
  9. 9.
    Moore, G.E. Jan. 1973. The future of cultured lymphocytes In: “Birth Defects, Original Article Series,” “Long-term Lymphocyte Cultures in Human Genetics.” The National Foundation - March of Dimes. Vol IX (No. 1 ): 13–19.Google Scholar
  10. 10.
    McGarrity, G.J. 1976. Spread and control of mycoplasmal infection of cell cultures. In Vitro 12: 643–648.Google Scholar
  11. 11.
    Barile, M.F., H.E. Hopps, M.W. Grabowski and D.B. Riggs. 1973. The identification and sources of mycoplasmes isolated from contaminated cell cultures. Ann. N.Y. Academy Sciences 225: 251–264.CrossRefGoogle Scholar
  12. 12.
    Crawford, Y.E. and W.H. Kraybill. 1967. The mixtures of mycoplasma species isolated from the human oropharynx. Ann. N.Y. Acad. Sciences 143: 411–421.CrossRefGoogle Scholar
  13. 13.
    Taylor-Robinson, D. and P.M.Furr. 1973. The distribution of T-mycoplasmas within and among various animal species. Ann. N.Y. Acad. Sciences. 225: 108–117.CrossRefGoogle Scholar
  14. 14.
    Murphy, W.H., C. Bullis, L. Cabick and R. Heyn. 1970. Isolation of mycoplasma from leukemic and nonleukemic patients. J. Nat. Cancer Inst. 45: 243–251.PubMedGoogle Scholar
  15. 15.
    Murphy, W.H., C. Bullis, I.J. Ertel and C.J.D. Zarafonetis. 1967. Mycoplasma studies of human leukemia. Ann. N.Y. Acad. Sci. 143: 544–556.PubMedCrossRefGoogle Scholar
  16. 16.
    Barile, M.F. 1967. Mycoplasma and leukemia. Ann. N.Y. Acad. Sci. 143: 557–572.PubMedCrossRefGoogle Scholar
  17. 17.
    Ginsburg, H. and J. Nicolet. 1973. Extensive transformation of lymphocytes by a mycoplasma organism. Nature New Biol. 246: 143–146.PubMedCrossRefGoogle Scholar
  18. 18.
    Fernald, G.W. 1972. In vitro response of human lymphocytes to Mycoplasma pneumoniae. Infec. Immun. 5: 552–558.Google Scholar
  19. 19.
    Levanthal, B.G., C.B. Smith, P.P. Carbone and E.M. Hersh. 1967. Lymphocyte transformation in response to M. pneumoniae. In: Proceedings of the Third Annual Leucocyte Culture Conference ( W.O. Rieke, ed.) Appleton-Century Crofts, N.Y.Google Scholar
  20. 20.
    Gregory, J.E. and J.L.Chisom. 1976. Mycoplasma salivarium in the blood of a child with leukemia. Abstract D70. Proceedings of the 76th Annual Meeting, American Society for Microbiology.Google Scholar
  21. 21.
    Archer, D.L. and B.G. Young. 1974. Control of interferon migration inhibition factor and expression of viral capsid antigens in Burkitt’s lymphoma-derived cell lines: role of L-arginine. Infect. Immun. 9: 684–689.Google Scholar
  22. 22.
    Barile, M.F. and B.G. Leventhal. 1968. Possible mechanism for mycoplasmal inhibition of lymphocyte transformation induced by phytohemagglutinin. Nature 219: 751–752.CrossRefGoogle Scholar
  23. 23.
    Rinaldo, C.R., Jr., B.C. Cole, J.C. Overall, Jr., J. R. Ward and L.A. Glasgow. 1974. Induction of interferon in ovine leukocytes by species of Mycoplasma and Acholeplasma. Proc. Soc. Exp.Biol. Med. 146: 613–618.PubMedGoogle Scholar
  24. 24.
    Rinaldo, C.R., Jr., J.C. Overall, Jr., B.C. Cole and L.A. Glasgow. 1973. Mycoplasma-associated induction of interferon in ovine leukocytes. Infect. Immunity 8: 796–803.Google Scholar
  25. 25.
    Rinaldo, C.R, Jr., B.C. Cole, J.C. Overall, Jr. and L.A. Glasgow. 1974. Induction of interferon in mice by mycoplasmas. Infect. Immunity 10: 1296–1301.Google Scholar
  26. 26.
    DeClerq, E. and T.C. Merigan. 1971. Bis-DEAE-fluorenone: mechanism of antiviral protection and stimulation of interferon production in the mouse. J. Infect. Dis. 123: 190–199.CrossRefGoogle Scholar
  27. 27.
    Stringfellow, D.A. and L.A. Glasgow. 1972. Tilorone hydrochloride: an oral interferon-inducing agent. Antimicrob. Ag. Chemother. 2: 73–78.CrossRefGoogle Scholar
  28. 28.
    Stinebring, W.R. and J.S. Youngner. 1964. Patterns of interferon appearance in mice injected with bacteria or bacterial endotoxin. Nature 204: 712.PubMedCrossRefGoogle Scholar
  29. 29.
    Finkelstein, M.S., G.H. Bausch and T.C. Merigan. 1968. Interferon inducers in vivo: difference in sensitivity to inhibitors of RNA and protein synthesis. Science 161: 465–468.PubMedCrossRefGoogle Scholar
  30. 30.
    Subrahmanyan, T.P., and C.A. Mims. 1970. Interferon production by mouse peritoneal cells. J. Reticuloendothel Soc. 7:32–42PubMedGoogle Scholar
  31. 31.
    Stringfellow, D.A. and L. A. Glasgow. 1972. Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents. Infect. Immunity 6: 743–747.Google Scholar
  32. 32.
    Cole, B.C., J.C. Overall, Jr., P.S. Lombardi, and L.A. Glasgow. 1976. Induction of interferon in ovine and human lymphocyte cultures by mycoplasmas. Infec. Immun. 14: 88–94.Google Scholar
  33. 33.
    Plata, E.J., M.R. Abell and W.H. Murphy. 1973. Induction of leukemoid disease in mice by Mycoplasma fermentans. Inf. Dis. 128: 588–597.CrossRefGoogle Scholar
  34. 34.
    Gabridge, M.G. and D.D. Gamble. 1974. Independance of leukemoid potential and toxigenicity of Mycoplasma fermentans. J. Inf. Dis. 130: 664–668.CrossRefGoogle Scholar
  35. 35.
    Biberfeld, G. and G. Sterner. 1976. Effect of Mycoplasma pneumoniae infection on cell mediated immunity. Infection (Suppl. 1 ) 17–20.CrossRefGoogle Scholar
  36. 36.
    Coppermann, R. and H.E. Morton. 1966. Reversible inhibition of mitosis in lymphocyte cultures by non-viable mycoplasmas. Proc. Soc. Exp. Biol. Med. 123: 790–795.Google Scholar
  37. 37.
    Aula, P. and W.W. Nichols. 1967. The cytogenetic effects of mycoplasma in human leukocyte cultures. J. Cell Physiol. 70: 281–290.PubMedCrossRefGoogle Scholar
  38. 38.
    Kundsin, R.B., M. Ampola, S. Streeter and P. Neurath. 1971. Chromosomal aberrations induced by T strain mycoplasmas. J. Med. Gen. 8: 181–187.CrossRefGoogle Scholar
  39. 39.
    Fogh, J. and H. Fogh. 1973. Chromosome changes in cell culture induced by mycoplasma infection. Ann. N.Y. Acad. Sci. 225: 311–329.CrossRefGoogle Scholar
  40. 40.
    Parkinson, C.F. and P.B. Carter. 1975. Phagocytosis of Mycoplasma salivarium by human polymorphonuclear leukocytes and monocytes. Inf. Immun. 11: 405–414.Google Scholar
  41. 41.
    Parkinson, C.F. 1975. Histamine release from human leukocytes when stimulated by Mycoplasma salivarium. Infec. Immunity 11: 595–597.Google Scholar
  42. 42.
    McGarrity, G.J. 1975. Detection of mycoplasmas in cell culture. Tissue Culture Manual. 1: 113–116.CrossRefGoogle Scholar
  43. 43.
    McGarrity, G.J. 1975. Serum quality control. Tissue Culture Manual. 1: 167–169.CrossRefGoogle Scholar
  44. 44.
    McGarrity, G.J. 1975. Control of microbiological contamination. Tissue Culture Manual 1: 181–184.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1978

Authors and Affiliations

  • Gerard J. McGarrity
    • 1
  1. 1.Department of MicrobiologyInstitute for Medical ResearchCamdenUSA

Personalised recommendations